ANRT 와 협약

Sep 10, 2015PRESS RELEASESHit 1124

MedPacto Inc. and ANRT have entered into a collaboration agreement for the development of novel biologics and monoclonal antibodies to develop drugs and diagnosis. The collaboration will focus on the discovery and development of first-in-class therapies and diagnosis tools. Under the terms of the agreement, Medpacto, Inc. will share the outcome from the collaboration with ANRT

Previous thumbnail test
Next 메드팩토, 3번째 글로벌 공동 임상… 프레드 허친슨과 운영 계약